ArticleTherapeutic advances in infectious disease
Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017-2020).
Sophea Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.